0001209191-20-053710.txt : 20201005 0001209191-20-053710.hdr.sgml : 20201005 20201005170224 ACCESSION NUMBER: 0001209191-20-053710 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201002 FILED AS OF DATE: 20201005 DATE AS OF CHANGE: 20201005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman William CENTRAL INDEX KEY: 0001730229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 201224329 MAIL ADDRESS: STREET 1: C/O BELLICUM PHARMACEUTICALS, INC. STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-02 0 0001724521 Arcus Biosciences, Inc. RCUS 0001730229 Grossman William C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 Chief Medical Officer Common Stock 2020-10-02 4 A 0 100000 0.00 A 100600 D Stock Option (right to buy) 17.00 2020-10-02 4 A 0 100000 17.00 A 2030-10-01 Common Stock 100000 100000 D Represents the grant of restricted stock units that vest in quarterly installments after October 2, 2020, subject to the Reporting Person's continued service to the Company. The option is exercisable in 48 equal monthly installments after October 2, 2020, subject to the Reporting Person's continued service to the Company. /s/ Carolyn Tang, Attorney-in-Fact 2020-10-05